MAIA Biotechnology, Inc.
MAIA
$1.26
-$0.10-7.35%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 19.66% | 97.44% | 16.57% | 36.84% | -23.49% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.73% | 123.49% | 35.40% | 37.39% | -21.53% |
| Operating Income | 13.73% | -123.49% | -35.40% | -37.39% | 21.53% |
| Income Before Tax | -1.59% | -225.41% | 39.78% | 44.01% | 42.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.59% | -225.41% | 39.78% | 44.01% | 42.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.59% | -225.41% | 39.78% | 44.01% | 42.91% |
| EBIT | 13.73% | -123.49% | -35.40% | -37.39% | 21.53% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 31.56% | -134.24% | 55.86% | 64.41% | 64.71% |
| Normalized Basic EPS | 31.61% | -134.08% | 55.86% | 64.43% | 64.69% |
| EPS Diluted | 31.56% | -134.24% | 55.86% | 64.41% | 64.71% |
| Normalized Diluted EPS | 31.61% | -134.08% | 55.86% | 64.43% | 64.69% |
| Average Basic Shares Outstanding | 48.53% | 38.95% | 36.47% | 57.35% | 61.74% |
| Average Diluted Shares Outstanding | 48.53% | 38.95% | 36.47% | 57.35% | 61.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |